Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schumacher, H.
Right arrow Articles by Møller, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schumacher, H.
Right arrow Articles by Møller, J. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 46, 215-221
© 2000 The British Society for Antimicrobial Chemotherapy

Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime

Helga Schumachera,*, Jens Scheibelb and Jens Kjølseth Møllera

a Department of Clinical Microbiology, Aarhus University Hospital and b Department of Clinical Microbiology, The University Hospital in Copenhagen County, Denmark

The frequency of decreased susceptibility to cefuroxime and quinolones and the correlation between these drug resistance traits was investigated in clinical isolates of Klebsiella pneumoniae from two Danish counties. Eighty-three randomly selected clinical isolates of K. pneumoniae with decreased susceptibility to cefuroxime were examined for cross-resistance patterns and the production of ß-lactamases. The frequency of resistance to cefuroxime and ciprofloxacin has increased from <5% in 1990 to 15% and 7% in 1998, respectively. Two of the 83 isolates were multiply resistant and seemed to produce extended-spectrum ß-lactamases. However, cross-resistance to ciprofloxacin and other classes of drug in 68% of the remaining isolates indicates that other resistance mechanisms, such as penetration barriers, had probably been selected in these Danish isolates. The susceptibility to ciprofloxacin decreased successively with decreasing susceptibility to cefuroxime for K. pneumoniae. This did not occur in cefuroxime-resistant Escherichia coli.

* Corresponding author. Tel: +45-89493535; Fax: +45-89493540; E-mail: helga.schumacher{at}inet.uni2.dk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
O. Kallman, A. Motakefi, B. Wretlind, M. Kalin, B. Olsson-Liljequist, and C. G. Giske
Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels
J. Antimicrob. Chemother., November 1, 2008; 62(5): 986 - 990.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. Fuursted and H. Schumacher
Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model
J. Antimicrob. Chemother., September 1, 2002; 50(3): 421 - 424.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. Schumacher, S. Hoffmann, C. Holmboe, and J. K. Moller
A procedure for evaluation and documentation of susceptibility test methods using the susceptibility of Klebsiella pneumoniae to ciprofloxacin as a model
J. Antimicrob. Chemother., October 1, 2001; 48(4): 493 - 500.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.